
Veeral Sheth MD MBA, FACS
Glaucoma Related, Retinal Disease, Uveitis
Physician and Surgeon Clinical Assistant Professor, University of Illinois at Chicago
Join to view full profile
6320 159th StSte AOak Forest, IL 60452
Phone+1 708-687-2222
Fax+1 708-687-3829
Dr. Sheth is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Northwestern University (Kellogg)MBA, 2012 - 2014
University of ChicagoFellowship, Surgical Retina and Vitreous, 2010
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 2004 - 2008
West Suburban Medical CenterInternship, Transitional Year, 2004 - 2005
University of Illinois College of MedicineClass of 2004
Certifications & Licensure
IL State Medical License 2008 - 2029
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2011, 2014-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2014-2016
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2011, 2014-2016
Clinical Trials
- Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
- Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
- Age-Related Eye Disease Study 2 (AREDS2)
Publications & Presentations
PubMed
- Four-Year Outcomes of Faricimab in Diabetic Macular Edema in the RHONE-X Extension Trial: A Podcast.Veeral S Sheth, Stela Vujosevic
Ophthalmology and Therapy. 2026-10-01 - 1 citationsSummary of Research: Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results From the RHONE-X Extension Trial.Veeral S Sheth, Stela Vujosevic, Alex Kotak, Aachal Kotecha, Kara Gibson
Ophthalmology and Therapy. 2026-07-01 - Aqueous Humor Biomarkers, Efficacy, and Safety in Patients with Naïve Diabetic Macular Edema Treated with Faricimab: The ALTIMETER Study.Patricio G Schlottmann, Amani A Fawzi, Manuel Amador, Andreas Dieckmann, Kara Gibson
Ophthalmology Science. 2026-05-01
Books/Book Chapters
Press Mentions
Eluminex Biosciences Announces Phase 1b Single Ascending Dose Study Results of a Novel Pentavalent Trispecific Fusion Antibody (EB-105) in Patients with Diabetic Macular Edema (DME)June 9th, 2025
Oculis Accelerates Enrollment for Phase 3 DIAMOND Trials of OCS-01 Eye Drops in DMEOctober 21st, 2024
EyeSouth Partners Expands Clinical Research Division - Healthcare and Medical News for Atlanta PhysiciansJuly 9th, 2024
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish, Gujarati
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: